Subscription results of rights offering or equity-linked bonds (voluntary)

What happened

HLB Pharma / Subscription Results for Paid-in Capital Increase or Stock-Related Bonds, etc. (Voluntary Disclosure) / (2026.09.17)

Subscription Results for Paid-in Capital Increase or Stock-Related Bonds, etc. (Voluntary Disclosure)

1. Type of Securities HLB Pharma Co., Ltd. Common Stock

2. Method of Issuance Shareholder Allocation Paid-in Capital Increase

3. Subscription Target General Public Offering Subscribers (including High-Risk High-Return Investment Trusts, Venture Capital Investment Trusts)

4. Subscription Date 2026-09-16

5. Subscription Results Planned Issuance Shares: 10,762,332 shares Corresponding Subscription Shares: 26,581,654 shares Cumulative Subscription Shares: 36,421,052 shares Subscription Rate: 338.41%

6. Treatment of Fractional Shares and Lapsed Shares -

7. Other Matters for Reference in Investment Decisions

1. The '4. Subscription Date' above is the end date of the general public offering subscription period. (General public offering subscription period: September 15, 2026 ~ September 16, 2026)

2. Detailed Subscription Results

2-1. Existing Shareholder Subscription Details 1) Number of Shares to be Raised: 10,762,332 shares 2) New Share Acquisition Rights Certificate Subscription Shares: 8,669,347 shares 3) Oversubscription Shares: 1,170,051 shares (Oversubscription Allocation Ratio: 100%) 4) Total Subscription Shares: 9,839,398 shares 5) Subscription Rate (Existing Shareholders): 91.42%

2-2. General Public Offering Subscription Details 1) General Public Offering Target Shares: 922,934 shares 2) General Investor Subscription Shares: 24,196,654 shares 3) High-Risk High-Return Investment Trust Subscription Shares: 1,770,000 shares 4) Venture Capital Investment Trust Subscription Shares: 615,000 shares 5) Total General Subscription Shares: 26,581,654 shares 6) Subscription Rate: 2,880.13%

3. The 'Planned Issuance Shares' in '5. Subscription Results' above represents the total number of shares to be issued through this paid-in capital increase.

4. The 'Corresponding Subscription Shares' in '5. Subscription Results' above corresponds to the general public offering subscription portion for lapsed shares (922,934 shares) arising after existing shareholder (new share acquisition rights certificate holder) subscription.

5. The 'Cumulative Subscription Shares' in '5. Subscription Results' above is the simple sum of existing shareholder subscription shares and general public offering subscription shares.

6. Future Schedule 1) Refund and Share Payment Date: September 18, 2026 2) Scheduled Listing Date of New Shares: October 7, 2026

Related Disclosures: 2026-09-15 Subscription Results for Paid-in Capital Increase or Stock-Related Bonds, etc. (Voluntary Disclosure) 2026-09-08 Investment Prospectus 2026-09-08 Securities Registration Statement (Equity Securities) 2026-09-08 Paid-in Capital Increase Decision (Shareholder Allocation with General Public Offering for Lapsed Shares) 2026-09-08 Final Issuance Price Determination for Paid-in Capital Increase